Page last updated: 2024-08-24

hrp 112 and Weight Gain

hrp 112 has been researched along with Weight Gain in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cromie, MA; Garceau, RJ; Kaunitz, AM1
Kaunitz, AM1
Bahamondes, L; Diaz, J; Hall, P; Petta, C1
el-Hussinie, M; el-Nahal, N; Hassan, EO1

Reviews

1 review(s) available for hrp 112 and Weight Gain

ArticleYear
Injectable long-acting contraceptives.
    Clinical obstetrics and gynecology, 2001, Volume: 44, Issue:1

    Topics: Affect; Bone Density; Chemistry, Pharmaceutical; Contraceptive Agents, Female; Contraindications; Delayed-Action Preparations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Patient Education as Topic; Patient Selection; Pharmacoepidemiology; Risk Factors; United States; United States Food and Drug Administration; Weight Gain

2001

Trials

2 trial(s) available for hrp 112 and Weight Gain

ArticleYear
Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lu
    Contraception, 1999, Volume: 60, Issue:4

    Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Metrorrhagia; Norethindrone; Patient Compliance; Pregnancy; Weight Gain

1999
Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects.
    Contraception, 1999, Volume: 60, Issue:2

    Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Egypt; Estradiol; Female; Humans; Injections, Intravenous; Medroxyprogesterone Acetate; Norethindrone; Patient Compliance; Weight Gain

1999

Other Studies

1 other study(ies) available for hrp 112 and Weight Gain

ArticleYear
Weight variation in users of the once-a-month injectable contraceptive Cyclofem.
    Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1998, Volume: 14, Issue:4

    Topics: Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Menstrual Cycle; Weight Gain

1998